The BIO International Convention Kicks Off Four Days of Breakthrough Programming in San Diego

World’s largest biotechnology event returns to the genomics capital
of the world

SAN DIEGO–(BUSINESS WIRE)–The 2017 BIO International Convention (BIO 2017), the world’s largest
gathering of the biotechnology industry, today kicked off four days of
inspiring keynotes with world luminaries, dynamic fireside chats with
industry leaders and compelling educational programming united under the
theme of “Breakthrough.”

Hosted by the Biotechnology Innovation Organization (BIO), BIO 2017 this
year returns to the San Diego Convention Center, where 16,000
biotechnology industry leaders from 48 states and 76 countries will
gather to examine the insights, challenges and opportunities surrounding
the next generation of biotechnology innovations.

BIO 2017 will feature 1,800 exhibitors and will likely include 40,000
partnering meetings facilitated through BIO’s One-on-One Partnering™
system.

Convention Highlights Include:

  • Keynote: David
    Cameron, Former Prime Minister of the United Kingdom

    Tuesday,
    June 20

    David Cameron will be interviewed by BIO President
    & CEO Jim Greenwood for a worldly discussion on the rapidly changing
    political landscape both in the United States and abroad. BIO will
    also recognize BioGENEius student award winners and introduce BIO’s
    new Board Chair, John Maraganore, Ph.D.

    9:00 – 10:30 a.m. |
    Ballroom 20, Upper Level

    • PLEASE NOTE: Keynotes are open to Convention Access and
      Partnering Attendees. Seating is first-come, first-served.
  • Keynote: Ann
    Romney, Wife of Mitt Romney, Patient Advocate and Best-Selling Author

    Wednesday,
    June 21

    Ann Romney will take the stage to discuss her
    experience living with Multiple Sclerosis and share personal stories
    of trials and tribulations as a patient. With remarkable stories and
    insights that will touch all audiences, her valued perspective on her
    life in and out of the political spotlight is engaging and
    informative. BIO President & CEO, Jim Greenwood, will also give his
    annual “State of the Biotechnology Industry” address, discussing the
    latest challenges, opportunities and breakthroughs facing the
    biotechnology industry.

    9:00 – 10:30 a.m. | Ballroom
    20, Upper Level

    • PLEASE NOTE: Keynotes are open to Convention Access and
      Partnering Attendees. Seating is first-come, first-served.
  • Fireside Chat: David
    Hung, MD, Chief Executive Officer, Axovant Sciences

    Tuesday,
    June 20

    Join us for a fireside chat with David T. Hung,
    MD, Chief Executive Officer at Axovant Sciences. Dr. Hung has served
    as the Chief Executive Officer and as a member of the Board since
    April 2017.

    11:00 a.m. – 12:00 p.m. | Room 6A, Upper Level
  • Fireside Chat: Francis
    deSouza, President & CEO, Illumina

    Wednesday, June
    21

    Join us for a fireside chat with Francis deSouza,
    President & CEO of Illumina. Francis deSouza was appointed President &
    CEO of Illumina in 2016 and is responsible for directing all aspects
    of company strategy, planning and operations. He initially joined the
    company as President in 2013 and led Illumina’s business units and
    core functions responsible for envisioning, developing and producing
    the company’s products.

    11:00 a.m. – 12:00 p.m. | Room 5B,
    Upper Level
  • Fireside Chat: Kathleen
    “Kate” Rubins, PhD, Astronaut, NASA

    Wednesday, June 21
    Join
    us for a fireside chat with Kate Rubins, NASA Astronaut. Kate was
    selected by NASA in 2009 and completed her first spaceflight on
    Expedition 48/49, where she became the first person to sequence DNA in
    space. She spent 115 days in space and conducted two spacewalks.

    1:45
    – 2:45 p.m. | Room 5B, Upper Level

Monday Highlights Include:

  • Press Conference: Synthetic
    Biology Breaks New Ground

    The promise of synthetic
    biology is on full display. Synthetic Genomics, Inc. and ExxonMobil
    will discuss scientific breakthroughs – soon to be published in a
    major peer reviewed journal – for developing a “fat and fit” algae
    strain with high oil production and rapid growth for the production of
    a renewable, low-emission alternative to legacy fossil fuel. This
    program represents a key area of research in ExxonMobil’s broader
    advanced biofuels and sustainable energy research portfolio.

    10:00
    – 11:00 a.m. | Press Conference Room 32B, Upper Level
  • Press Conference: Cracking
    the Code: the Economic Impact of San Diego’s Genomics Industry

    Personalized
    medicine and technology are shaping the future of healthcare as we
    know it, with San Diego’s genomics companies, research institutions
    and universities at the forefront. Quantifying this impact, San Diego
    Regional EDC will release the first-ever study on the San Diego
    region’s genomics industry. “Cracking the Code: the Economic Impact of
    San Diego’s Genomics Industry” includes a comparative analysis of the
    top ten U.S. metros for life sciences, as well as an assessment of
    local firms, jobs, venture capital and much more. Behind the data is a
    story of how this once nascent sequencing technology is now shaping
    the future of global medicine and discovery, but also how it has
    altered the DNA of the entire San Diego region.

    12:00 – 12:30
    p.m. | Press Conference Room 32B, Upper Level
  • Fireside Chat: Brent
    Saunders, Chairman, President and Chief Executive Officer, Allergan plc

    Join
    us for a fireside chat with Brent Saunders, Chairman, President and
    Chief Executive Officer at Allergan plc. Mr. Saunders has significant
    healthcare industry expertise and a proven track-record leading
    business transformations and integrations.

    2:00 – 2:45 p.m. |
    Room 5B, Upper Level
  • Super Session: So
    Many Choices: What’s the Right Biomanufacturing Strategy for Me?

    When
    a biologics company is preparing to launch a new product, the
    decision-making process can be daunting. Join us as we review the
    formidable challenges and decisions facing biopharma manufacturing
    executives. With business strategies and decision-making processes
    varying significantly from one biopharma to the next, our panel of
    industry experts will share their unique insights and perspectives and
    demonstrate how there is really no one-size-fits-all solution in
    biomanufacturing, regardless of company size.

    2:30 – 3:45
    p.m. | Room 6B, Upper Level
  • Fireside Chat: Lloyd
    Minor, MD, Dean, Stanford University School of Medicine

    Join
    us for a one-on-one conversation with Dean Lloyd Minor, MD, a
    scientist, surgeon and academic leader. He is the Carl and Elizabeth
    Naumann Dean of the Stanford University School of Medicine, and a
    professor of otolaryngology–head and neck surgery, bioengineering and
    neurobiology, by courtesy, at Stanford University. As dean, Minor
    plays an integral role in setting strategy for the clinical enterprise
    of Stanford Medicine, which includes Stanford Health Care and Stanford
    Children’s Health. Under his leadership, Stanford Medicine has
    established a strategic vision to lead the biomedical revolution in
    precision health.

    3:00 – 4:00 p.m. | Room 5B, Upper Level
  • Press Conference: Freedom
    from Cancer Startup Challenge Launch

    The Center for
    Advancing Innovations will announce the Launch of the Freedom from
    Cancer Startup Challenge.

    3:00 – 4:00 p.m. | Press Conference
    Room 32B, Upper Level
  • Media Event: BIO
    Ventures for Global Health (BVGH)

    Join BIO President
    and CEO, Jim Greenwood, and other notable speakers at the Africa
    Pavilion Media Event. Learn about the importance of the African market
    for the biotech industry and promising partnership opportunities. Hear
    from Africa Pavilion exhibitors about innovations coming out of the
    region, as well as prominent stakeholders, including Dr. Verna
    Vanderpuye from AORTIC, Dr. Philippe Cupers from the European
    Commission and others. BIO Ventures for Global Health (BVGH) will also
    be announcing their newest program that targets the emerging cancer
    crisis on the African continent: the African Access Initiative (AAI).
    AAI will officially be launched at the 2017 BIO Convention. Don’t miss
    out on this unique opportunity to hear from industry leaders and
    “visit” 24 African countries.

    3:30 – 4:30 p.m. |
    Booth 243

Follow the 2017 Convention @BIOConvention,
and join the conversation and @IAmBIOtech.

Media registration is open on Monday from 7:00 a.m. – 5:00 p.m. and on
Tuesday from 6:30 a.m. – 3:00 p.m. at the San Diego Convention Center.
The majority of attendees, 70 percent, are c-level executives. They
split evenly from large companies of 500 or more employees and small
companies of 50 employees or less.

The BIO International Convention is the largest global event for the
biotechnology industry and attracts the biggest names in biotech, offers
key networking and partnering opportunities, and provides insights and
inspiration on major trends affecting the industry. The Convention will
highlight the latest trends and the newest opportunities for executives,
investors, scientists, policy leaders, and media from around the world.
Speakers at the sessions will share breakthroughs in medicine,
diagnostics, the environment, energy production, business operations,
financing, partnerships, policy issues and food and agriculture. Visit http://convention.bio.org/
for the most up-to-date program and speaker information.

About BIO

BIO is the world’s largest trade association representing biotechnology
companies, academic institutions, state biotechnology centers and
related organizations across the United States and in more than 30 other
nations. BIO members are involved in the research and development of
innovative healthcare, agricultural, industrial and environmental
biotechnology products. BIO also produces the BIO
International Convention
, the world’s largest gathering of the
biotechnology industry, along with industry-leading investor and
partnering meetings held around the world. BIOtechNOW is
BIO’s blog chronicling “innovations transforming our world” and the BIO
Newsletter is the organization’s bi-weekly email newsletter. Subscribe
to the BIO Newsletter
.

Upcoming BIO Events

BIO World Congress on Industrial Biotechnology
Montréal,
Canada
July 23-26, 2017

BIO Patient and Health Advocacy Summit
The Mayflower Hotel,
Washington, DC
October 2-3, 2017

BIO Investor Forum
San Francisco
October 17-18, 2017

Contacts

Biotechnology Innovation Organization (BIO)
Theresa Brady
202-962-9235
Web:
www.bio.org
Blog:
www.biotech-now.org
Twitter:
@IAmBiotech